BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization GlobeNewswire December 02, 2025 SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (“BGLC” or the “Company“), an emerging provider of precision oncology diagnostics with expanding […]